1. Bi, Yanping, Liu, Jie, Qin, Songbing, Yang, Haihua, Zhou, Suna. 2024. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer. In Frontiers in immunology, 15, 1295011. doi:10.3389/fimmu.2024.1295011. https://pubmed.ncbi.nlm.nih.gov/38562942/
2. Liu, Zanhua, Xu, Dafeng, Zhao, Yongbo, Zheng, Jing. 2010. Non-syndromic mild mental retardation candidate gene CDKL3 regulates neuronal morphogenesis. In Neurobiology of disease, 39, 242-51. doi:10.1016/j.nbd.2010.03.015. https://pubmed.ncbi.nlm.nih.gov/20347982/
3. Pang, Zhongqiu, Zhang, Hui, Zheng, Shaoqin, Zheng, Qianqian, Sheng, Ren. 2024. HNF4α-CDKL3 axis restricts MASLD progression by targeting FoxO1 via noncanonical phosphorylation. In Hepatology (Baltimore, Md.), , . doi:10.1097/HEP.0000000000001147. https://pubmed.ncbi.nlm.nih.gov/39658857/
4. Dubos, Aline, Pannetier, Solange, Hanauer, André. . Inactivation of the CDKL3 gene at 5q31.1 by a balanced t(X;5) translocation associated with nonspecific mild mental retardation. In American journal of medical genetics. Part A, 146A, 1267-79. doi:10.1002/ajmg.a.32274. https://pubmed.ncbi.nlm.nih.gov/18412109/